METTL3 and hepatocellular carcinoma: Taken together, these results suggest that the presence of splice variants of METTL3 (particularly METTL3-D) significantly reduces the level of m6A modification in normal tissues, while downregulation of METTL3-D in HCC tumors results in increased levels of m6A modification.